Testosterone replacement therapy and prostate cancer: A word of caution

被引：19
|
作者：
Brand T.C. [1 ]
Canby-Hagino E. [1 ]
Thompson I.M. [1 ]
机构：
[1] Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229
来源：
Current Urology Reports | 2007年 / 8卷 / 3期
关键词：
Prostate Cancer; Testosterone; Digital Rectal Examination; Free Testosterone; Prostatic Intraepithelial Neoplasia;
D O I：
10.1007/s11934-007-0004-x
中图分类号：
学科分类号：
摘要：
The number of men for whom testosterone is prescribed is rapidly Increasing. The aging man normally demonstrates a gradual decline in testosterone. Symptoms of hypogonadism include erectile dysfunction, diminished libido, sarcopenia, increased adiposity, osteopenia and osteoporosis, impaired cognition, and depression. There is a paucity of data regarding both efficacy and safety of testosterone replacement therapy. Testosterone levels have been shown to modulate prostate cancer risk and progression. A prospective evaluation of prostate cancer risk with testosterone replacement therapy has not been conducted. We outline concerns and recommendations for the use of testosterone replacement therapy in the aging man. Copyright © 2007 by Current Medicine Croup LLC.
引用
收藏
页码：185 / 189
页数：4
相关论文
共 50 条
  • [11] TESTOSTERONE REPLACEMENT THERAPY AFTER RADIATION THERAPY FOR PROSTATE CANCER
    Pastuszak, Alexander W.
    Pearlman, Amy M.
    Lipshultz, Larry I.
    Khera, Mohit
    JOURNAL OF UROLOGY, 2012, 187 (04): : E603 - E603
  • [12] Shifting the Paradigm of Testosterone Replacement Therapy in Prostate Cancer
    Bell, Michael A.
    Campbell, Jeffrey D.
    Joice, Gregory
    Sopko, Nikolai A.
    Burnett, Arthur L.
    WORLD JOURNAL OF MENS HEALTH, 2018, 36 (02): : 103 - 109
  • [13] Use of testosterone replacement therapy in patients with prostate cancer
    Dorff T.B.
    Vogelzang N.J.
    Current Urology Reports, 2011, 12 (3) : 223 - 228
  • [14] Effect of testosterone administration to men with prostate cancer is unpredictable: a word of caution and suggestions for a registry
    Morales, Alvaro
    BJU INTERNATIONAL, 2011, 107 (09) : 1369 - 1373
  • [15] Hypofractionation for prostate cancer: a word of caution
    Bossi, Alberto
    Blanchard, Pierre
    LANCET ONCOLOGY, 2016, 17 (04): : 406 - 407
  • [16] Testosterone replacement therapy and the prostate
    Tenover J.L.
    Current Sexual Health Reports, 2007, 4 (2) : 79 - 82
  • [17] Testosterone replacement therapy in men with prostate cancer after proton therapy
    Bryant, Curtis
    Hoppe, Bradford S.
    Mendenhall, Nancy P.
    Henderson, Randal H.
    Nichols, Romaine Charles
    Morris, Christopher G.
    Williams, Christopher R.
    Su, Zhong
    Li, Zuofeng
    Mendenhall, William M.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [18] Testosterone replacement therapy and cardiovascular risk: TRAVERSE with caution
    Krishnan, Srikanth
    Aldana-Bitar, Jairo
    Golub, Ilana
    Kianoush, Sina
    Benzing, Travis
    Ichikawa, Keishi
    Budoff, Matthew J.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2024, 86 : 73 - 74
  • [19] Testosterone replacement and prostate cancer
    Ramasamy, Ranjith
    Fisher, Erik S.
    Schlegel, Peter N.
    INDIAN JOURNAL OF UROLOGY, 2012, 28 (02) : 123 - 128
  • [20] Testosterone replacement therapy and the risk of prostate cancer: a perspective view
    Barqawi, AB
    Crawford, ED
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2005, 17 (05) : 462 - 463
12345